Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00036114 |
|
Recruitment Status :
Completed
First Posted : May 9, 2002
Last Update Posted : November 11, 2013
|
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Information provided by:
Otsuka Pharmaceutical Development & Commercialization, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Alzheimer Disease | Drug: aripiprazole | Phase 3 |
| Study Type : | Interventional (Clinical Trial) |
| Primary Purpose: | Treatment |
| Study Start Date : | March 2000 |
| Actual Primary Completion Date : | August 2003 |
| Actual Study Completion Date : | August 2003 |
Resource links provided by the National Library of Medicine
MedlinePlus Genetics related topics:
Alzheimer disease
Drug Information available for:
Aripiprazole
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 55 Years to 95 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Institutionalized patients with Alzheimer's
Information from the National Library of Medicine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00036114
Locations
| United States, Alabama | |
| Local Institution | |
| Tuscaloosa, Alabama, United States | |
| United States, Arizona | |
| Local Institution | |
| Scottsdale, Arizona, United States | |
| United States, California | |
| Local Institution | |
| Cerritos, California, United States | |
| Local Institution | |
| Granada Hills, California, United States | |
| Local Institution | |
| Los Angeles, California, United States | |
| Local Institution | |
| San Diego, California, United States | |
| Local Institution | |
| Torrance, California, United States | |
| United States, Colorado | |
| Local Institution | |
| Denver, Colorado, United States | |
| United States, Connecticut | |
| Local Institution | |
| Hamden, Connecticut, United States | |
| United States, Florida | |
| Local Institution | |
| Miami, Florida, United States | |
| Local Institution | |
| North Miami Beach, Florida, United States | |
| Local Institution | |
| West Palm Beach, Florida, United States | |
| United States, Georgia | |
| Local Institution | |
| Atlanta, Georgia, United States | |
| Local Institution | |
| Augusta, Georgia, United States | |
| Local Institution | |
| Macon, Georgia, United States | |
| United States, Hawaii | |
| Local Institution | |
| Honolulu, Hawaii, United States | |
| United States, Illinois | |
| Local Institution | |
| North Chicago, Illinois, United States | |
| Local Institution | |
| Springfield, Illinois, United States | |
| United States, Louisiana | |
| Local Institution | |
| New Orleans, Louisiana, United States | |
| Local Institution | |
| Shreveport, Louisiana, United States | |
| United States, Maryland | |
| Local Institution | |
| Baltimore, Maryland, United States | |
| United States, Massachusetts | |
| Local Institution | |
| Newton Center, Massachusetts, United States | |
| Local Institution | |
| Springfield, Massachusetts, United States | |
| Local Institution | |
| Wellesley Hills, Massachusetts, United States | |
| United States, New Jersey | |
| Local Institution | |
| Lyons, New Jersey, United States | |
| United States, New York | |
| Local Institution | |
| Albany, New York, United States | |
| Local Institution | |
| Lawrence, New York, United States | |
| Local Institution | |
| Montrose, New York, United States | |
| Local Institution | |
| Northport, New York, United States | |
| Local Institution | |
| White Plains, New York, United States | |
| United States, North Carolina | |
| Local Institution | |
| Raleigh, North Carolina, United States | |
| United States, Ohio | |
| Local Institution | |
| Beachwood, Ohio, United States | |
| United States, Oregon | |
| Local Institution | |
| Portland, Oregon, United States | |
| United States, Pennsylvania | |
| Local Institution | |
| Hershey, Pennsylvania, United States | |
| United States, Texas | |
| Local Institution | |
| Austin, Texas, United States | |
| Local Institution | |
| Dallas, Texas, United States | |
| Local Institution | |
| San Antonio, Texas, United States | |
| Local Institution | |
| Wichita Falls, Texas, United States | |
| United States, Vermont | |
| Local Institution | |
| Bennington, Vermont, United States | |
| United States, Virginia | |
| Local Institution | |
| Charlottesville, Virginia, United States | |
| United States, Washington | |
| Local Institution | |
| Seattle, Washington, United States | |
Sponsors and Collaborators
Otsuka Pharmaceutical Development & Commercialization, Inc.
| ClinicalTrials.gov Identifier: | NCT00036114 |
| Other Study ID Numbers: |
CN138-004 |
| First Posted: | May 9, 2002 Key Record Dates |
| Last Update Posted: | November 11, 2013 |
| Last Verified: | April 2011 |
Keywords provided by Otsuka Pharmaceutical Development & Commercialization, Inc.:
|
Psychosis associated with dementia of the Alzheimer's type |
Additional relevant MeSH terms:
|
Alzheimer Disease Dementia Brain Diseases Central Nervous System Diseases Nervous System Diseases Tauopathies Neurodegenerative Diseases Neurocognitive Disorders Mental Disorders Aripiprazole Antidepressive Agents Psychotropic Drugs Antipsychotic Agents Tranquilizing Agents |
Central Nervous System Depressants Physiological Effects of Drugs Dopamine Agonists Dopamine Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Serotonin 5-HT1 Receptor Agonists Serotonin Receptor Agonists Serotonin Agents Serotonin 5-HT2 Receptor Antagonists Serotonin Antagonists Dopamine D2 Receptor Antagonists Dopamine Antagonists |